CA
NZ
UK
AU
IND
US
Kun Zhang, Acting Chief Financial Officer of Jinko Holdings Ltd, filed an initial statement of beneficial ownership on November 9, 2026, with a triggering event date of October 30, 2026.
Mentari Therapeutics, Inc., formerly known as InMed Pharmaceuticals Inc., filed a Form 8-K current report on November 9, 2026, announcing the completion of its previously disclosed merger with Mentari Therapeutics, Inc., a Delaware corporation.
LKQ Corporation filed a current report on November 9, 2026, disclosing that Salvatore A. Abbate's start date as President and Chief Executive Officer and Board member was accelerated from December 15, 2026 to November 9, 2026.
Quanterix Corporation filed a Form 8-K with the SEC on November 9, 2026, announcing its financial results for the third fiscal quarter ended September 30, 2026, alongside presentation slides furnished for its earnings call held the same day.
King Resources Global, Inc. filed a Form 8-K on November 9, 2026, disclosing that its wholly owned subsidiary Heavenly Grace entered into three separate purchase agreements on November 5, 2026, to acquire a total of 19 collectible items from Grand View Assets Limited for …
Jasper Therapeutics, Inc. filed a Form 8-K on November 9, 2026, announcing the results of its completed offer to purchase all outstanding warrants issued in its September 18, 2025 underwritten public offering.
OPAL Fuels Inc. filed a Current Report on Form 8-K on November 9, 2026, furnishing a press release covering its financial results for the quarter ended September 30, 2026.
Trinseo PLC filed a Form 8-K on November 9, 2026, disclosing the issuance of a press release announcing its financial results for the third quarter and year ended September 30, 2026.
Shmuel Barel, Chief Marketing Officer of Wearable Devices Ltd., filed a Form 4 on November 9, 2026, disclosing the acquisition of 20,000 Restricted Share Units on November 5, 2026, at a price of $0 per unit under the company's 2024 Global Equity Incentive Plan.
RB Global, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting condensed consolidated financial results for the three and nine months ended that date.
Please wait processing your request...